Amino Acid Boosts Colistin Effectiveness Against Resistant Infections

Antibiotic resistance is a growing global crisis, linked to millions of deaths annually and driven by rising resistant infections, according to the World Health Organization. Colistin, a last-resort antibiotic used when other treatments fail, is increasingly ineffective as colistin-resistant infections become more common, leaving patients with fewer options. New research shows that adding a specific amino acid can boost colistin's effectiveness, potentially restoring its power against resistant bacteria. This discovery matters because it could extend the usefulness of an existing drug, offering a faster and more cost-effective strategy than developing entirely new antibiotics. By enhancing colistin's activity, this approach may help address the urgent need for new therapeutic approaches against drug-resistant infections. Further studies are needed to confirm these findings in clinical settings.